Melanoma 2024: 34th Annual Cutaneous Malignancy Update

• Agenda
• Brochure (PDF, 320 KB)
• Exhibitor Prospectus (PDF, 440 KB)
• Faculty Disclosures (PDF, 140 KB)
• Maintenance of Certification
• Cultural & Linguistic Competency Resources (PDF, 100 KB)
• Health and Safety Waiver and Assumption of Risk (PDF, 93 KB)

As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.

After attending this live activity, participants should be able to:

• Demonstrate how newly discovered, evidence-based scientific information applies to the current practice of clinical dermatology.
• Describe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma.
• Examine current data and new strategies for the prevention of melanoma.
• Relate case studies to other healthcare professionals to improve patient care.
• Evaluate and diagnose a variety of malignancies related to melanoma skin cancer.
• Identify possible genetic mutations and etiologic factors in the melanoma patient and diagnose patients based on dermatologic manifestations.
• Incorporate new diagnostic techniques, including dermoscopy, into practice.
• Determine appropriate treatment for patients with metastatic melanoma, melanonychia and ocular melanoma.
• Integrate new therapies and treatments for advanced melanoma including surgical techniques.
• Discuss the effectiveness of neoadjuvant therapy and immunotherapy in treating melanoma.
• Navigate the medico-legal aspects of caring for the melanoma patient.
• Recommend strategies for managing patients with multiple melanomas.
• Provide optimal follow-up of patients after melanoma treatment.

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Scripps Health designates this live activity for a maximum of 13 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit Breakdown

Dermoscopy Workshop (Fri): 2

Main Conference (Sat-Sun): 11

Total Credit Available: 13 

Nurses and Nurse Practitioners

For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.

For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.

The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Physician Assistants

NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Pharmacists

The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit(s)™.

Commercial Support

This course is supported, in part, by educational grants from industry. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, a complete list of commercial support received will be provided to all learners who participate in the continuing education activity. For more information: www.accme.org/standards

Cultural & Linguistic Competency and Implicit Bias

This activity is designed to include curriculum addressing the topics of cultural and linguistic competency (CLC) and implicit bias (IB) in compliance with California Business and Professions (B&P) Code Section 2190. All those involved in the planning and execution of this activity have been asked to identify and discuss issues relevant to the topics being covered. In addition, a variety of resources are available that address cultural and linguistic competency and implicit bias. A resource document can be downloaded from the Conference Details section above.

American Board of Otolaryngology – Head and Neck Surgery (ABOHNS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

American Board of Pathology (ABPATH)

Successful completion of this CME activity enables the learner to earn Lifelong Learning (CME) credit toward the CME requirement(s) of the American Board of Pathology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP credit.

MOC points will be awarded to physicians who successfully complete the requirements outlined in the post-activity evaluation. Points earned will be reported to the appropriate specialty board approximately 60 days post conference as long as all learner requirements are met. These credits will not appear on your CME certificate from Scripps.

Attendee Cancellation, Substitution and Refund

The course tuition is refundable, minus a $100 processing fee (MD, DO, RN, PA, NP) or a $50 processing fee (Scripps, MDA, Fellow, Resident, Student), if your cancellation is received in writing no later than Friday, January 12, 2024. Attendee substitutions are allowed, but notification must be made in writing by Friday, January 12, 2024. After this date, under no circumstances will refunds, credits, or substitutions be granted. No refunds or credits will be given to “no shows.” No refunds shall be made for cancellations due to inclement weather.

Scripps Conference Modification or Cancellation

Scripps reserves the right to modify the course’s schedule or program as necessary. Scripps also reserves the right to cancel this conference, in which case a full refund of the registration fee will be provided. Attendees who purchase non-refundable airline tickets do so at their own risk. Scripps encourages the purchase of travel insurance as we are unable to refund any travel costs (flight, hotel, etc.) in the case of Scripps cancellation.

Health and Safety Waiver and Assumption of Risk

By completion and submission of the online registration form, attendees certify they have read and fully understand the Health and Safety Waiver and Assumption of Risk Agreement.

Family and Guest Attendance Policy

All conference activities and meals are exclusively reserved for paid conference attendees. Children and family members are not allowed to attend meal functions or permitted in the meeting space.

Recording and Photography Clause

Scripps reserves exclusive rights to record (audio and video) and/or photograph all conference proceedings for use in marketing materials, presentations and course content sales.